No, pa razloži
Predvsem pa ta stavek malo razdelaj in trditve podkrepi s utemeljitvami: "Molnupiravir is mutagenic and toxic for human cells".
Se pravi, navedba konkretnih študij .
Early safety concerns accompanied Merck's molnupiravir, the first potential oral COVID-19 therapy
Merck and Ridgeback Biotherapeutics plan a EUA filing after announcing that molnupiravir could halve COVID-19 hospitalization or death risk.
www.drugdiscoverytrends.com